NCT01181141View on ClinicalTrials.gov

Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

February 28, 2010

Conditions
Venous Thromboembolism
Interventions
DRUG

DU-176b (edoxaban)

DRUG

Enoxaparin sodium 20mg

Trial Locations (1)

Unknown

Osaka

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY